opasan

You have to win the game to stop playing.

[paseq @xpaseqx]

🚀🇦🇺 Major tax reform could make Australia's economy world-class.

Christopher Joye's (@cjoye) bold blueprint:
- Permanently end bracket creep
- Flatter, simpler income tax (0% to 42%)
- Company tax cut to a flat 20%
- Zero CGT on first $20k gains + 10% IP rate
- Full instant expensing for business investment

Funded by lifting GST to 15% (broad base), a 50% NDIS trim, and slashing public service costs by 25%.

Net result? A modest surplus and a genuine productivity-led economy that rewards work, risk-taking and innovation instead of bureaucracy.

Australia doesn't lack money. It lacks courage. Time to choose.

#AusEconomy #TaxReform #Budget2026 #auspol

[Marko Matvikov @MarkoMatvikov]

If income tax wasn’t being increased by stealth (if it was indexed), it’d cost the federal budget about $9bn per year.

Or in other words, almost 15 million workers would get to keep an extra $9bn per year of the wages they earned.

To put this into context:

• NDIS will cost over $55bn per year for less than 1m participants, with much of it being defrauded

• Lost revenue from illegal tobacco is about $10bn per year because we taxed it into the black market

• Interest repayments on government debt will cost over $26bn per year with no plan to pay it off

Misplaced priorities, well-intended failures, utter incompetence - call it whatever you like.

Regular people are hurting - and those who support these settings are complicit in this betrayal.

[Tony Tardio @tonytardio]

NEVER EVER TRUST A POLITICIAN.NEVER.

[Costa2 @costa0070]

“My word is my bond “ @AlboMP

[opasan @robocop7346]

@Ausproperty95 @dripgrillionair Best approach would be to target industries that have some level of strategic importance - incentives to bring them back, tax, demand guarantees, etc. I wouldn't necessarily chase every industry that has left.

[opasan @robocop7346]

“In settings where traditional tools like CT and MRI may be inaccessible and specialised operators are scarce, this capability is invaluable" $emv

https://t.co/mPfHFBt86G

[opasan @robocop7346]

$emv

[TechInvest @techinvestmag]

EMVision Medical Devices (#ASX: $EMV) has established its pilot commercial production line and received the final $1,250,000 non-dilutive cash payment under the Modern Manufacturing Initiative (MMI) grant programme.
https://t.co/UMBTcU9G3Q

[Alessandro Sticchi @Sticchi_Alex]

Brilliant presentation at #NYValves2024 from @SusheelKodaliMD on the #DurAVR @AnterisTech with very interesting results from this valve showing a new intriguing technology!

@azeemlatib @chrismeduri @NicolasVanMiegh @JoaoLCavalcante @MReardon19 @bapat_savrtavr @mirvatalasnag

[opasan @robocop7346]

@lukKOMe @cjoye Should we tell him? Or just wait..

[opasan @robocop7346]

$avr

[TCTMD @TCTMD]

Discharge data from the DurAVR™ THV EFS study reveals paradigm-shifting hemodynamic performance. Learn more about the new class of TAVR, a single-piece, native-shaped biomimetic design. https://t.co/L4U2h68RVz

#Sponsored #TAVR #TAVI #TCT2023 @azeemlatib

[TCTMD @TCTMD]

Discharge data from the DurAVR™ THV EFS study reveals paradigm-shifting hemodynamic performance. Learn more about the new class of TAVR, a single-piece, native-shaped biomimetic design. https://t.co/L4U2h68RVz

#Sponsored #TAVR #TAVI #TCT2023 @azeemlatib

[Wayne Paterson @CEOPaterson]

Great way to end a great week. Meeting with the V2V team to discuss our unique TEER device for mitral repair.Thanks to the Anteris team for all the work that culminated in a great #TCT for #AVR #movingtheconversationforward #proudtobeanteris

[Chris Meduri, MD MPH @chrismeduri]

It is with great pleasure to announce the completion of the DurAVR EFS enrollment! Thank you @umichCVC. This first-in-class biomimetic valve exceeded already remarkable prior results. More details next week in San Fran @TCTMD and in London as a LBCT @PCRonline. @AnterisTech #tavr

[Wayne Paterson @CEOPaterson]

@AnterisTech @tavrkapadia @ClevelandClinic Thanks Dr Kapadia, Dr Krishnaswamy and Dr Puri and your fantastic team for completing 3 more patients. Thanks to the patients as well for participating, great results by a great team. #proudtobeanteris#DurAVR#TCT

[Anteris Technologies @AnterisTech]

#AnterisTech is honored to be named 2023 Company of the Year by MedTech Outlook. Congratulations to the entire team! #ProudtoBeAnteris #Innovation #TAVI #TAVR #AorticStenosis $AVR

Read the Article Here: https://t.co/GMue6zyawp

[Thomas Waggoner @DrTomWaggoner]

Congrats to our phenomenal TMC SHD & CV Research Teams for implanting the first 2 DurAVR biomimetic TAVRs in ARIZONA, 2nd in the US! This could be transformative technology in the TAVR space. Will be very interesting to see how fast this potential disruptive advancement grows!

[Montefiore Heart @MonteHeart]

🎯 3rd patient successfully treated in #DurAVR THV US Early Feasibility Study

Thanks to @AnterisTech and @chrismeduri for the support!

@azeemlatib @m_assafin @EdwinHoMD @AndreaScotti21 @MeiChau3 @jesusdaiyan @jellyinoa @MontefioreNYC @EinsteinMed
@PCRonline @TCTMD @crfheart

[Anteris Technologies @AnterisTech]

#AnterisTech announces second valve-in-valve case with #DurAVR THV and achieves phenomenal results. @J_Sathananthan performed the procedure at Saint Paul’s Hospital, Vancouver
$AVR #TAVR #TAVI #Innovation #CardioTwitter #cardiology

Full Details: https://t.co/xtojctWhqT\

[Wayne Paterson @CEOPaterson]

Anteris’ starts US trial for DurAVR transcatheter heart valve
https://t.co/1ta4EgcgZ1 via @MedicalTechMag